Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law Firm
December 29, 2020 11:03 ET
|
Moore Kuehn
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm
November 12, 2020 12:25 ET
|
Moore Kuehn
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout
October 26, 2020 17:17 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
June 22 Deadline in Lawsuit for Investors in Cellular Biomedicine Group Inc (NASDAQ:CBMG) Shares Announced by Shareholders Foundation
June 01, 2015 09:55 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, June 01, 2015 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Cellular Biomedicine Group Inc...